[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Medication Management Market by Systems (CPOE, CDSS, Automated Dispensing, Assurance Systems), Services (Medication Analytics, POC Verification, ADE Surveillance), Mode of Delivery (On-Premises, Web-Based, Cloud-Based) - Global Forecast to 2019

August 2014 | 298 pages | ID: MD04D0FFD91EN
MarketsandMarkets

US$ 3,955.00 US$ 5,650.00 -30 %
Offer valid until March 31, 2024!

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Medication errors and adverse drug events have been one of the major contributors to hospital readmissions globally. These issues add to the overall healthcare expenditure of the country. Medication management systems help in minimizing medication errors and adverse drug events by effective verification, recording, and reporting of medication administered to patient at every point of care. Medication management systems also enable automated inventory management for healthcare providers in both in-patient and out-patient healthcare environment.

The global medication management market is largely driven by the growing need to minimize medication errors in the healthcare systems, and government initiatives in both developed and developing economies to curtail soaring healthcare expenditures. Other benefits of medication management systems, such as automated inventory management are also contributing to the greater uptake of medication management solutions by healthcare providers across the globe.

In this report, the global medication management market is broadly segmented by systems, services, mode of delivery, and end users. The market, by software, is further segmented into computerized physician order entry, clinical decision support systems, administration software, inventory management software, automated dispensing systems, and assurance systems. On the other hand, the market, by services, is segmented into medication analytics, point-of-care verification, and ADE (adverse drug events) surveillance services offered by medication management solutions vendors. The end-users market is segmented into hospitals, pharmacy, and other healthcare institutions, while based on the mode-of-delivery; the market is divided into on-premises, web-based, and cloud-based deployment models.

The medication management market has experienced strong growth over the past few years, and is further expected to grow at an approximate CAGR of 14%–16% during the forecast period of 2014 to 2019. The overall growth of this market is mainly driven by the rise in the ageing population, and the incidence of chronic illnesses leading to greater risks of medication errors. The government initiatives to reduce healthcare costs and improve quality of healthcare delivery are also propelling the growth of this market.

The services segment currently dominates the medication management systems market, with the remaining share being occupied by the software market. Further, the services market is expected to grow at a strong CAGR during the forecast period, owing to an increasing demand for point-of-care verification and ADE surveillance services in the developed economies.

Geographically, the emerging markets in the Asia-Pacific (APAC) and the Middle Eastern regions are expected to show a high growth rate in the coming years. South Korea and Singapore are expected to be the most promising markets for medication management systems in the APAC region.

Some major players in this market are CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions, Inc. (U.S.), Cerner Corporation (U.S.), and Omnicell, Inc. (U.S.). Emergence of smaller players operating at the regional levels has led to greater competitiveness in the medication management systems market over the years. Amidst the market growth and increasing competitiveness, many of the global players in the medication management systems market are trying to maintain their market share by developing new products and enhancing the existing ones, forming partnerships/alliances, and through acquisitions.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms, and allow them to gauge the pulse of the market, which in turn will help firms garner greater market shares. Firms purchasing the report could use one or a combination of the below mentioned strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for increasing their market shares.

The report provides insights on the following pointers:
  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the medication management market. The report analyzes the medication management market by systems, services, end-users, and mode of delivery.
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the medication management market.
  • Market Development: Comprehensive information about the lucrative emerging markets by product, functionality, and geography.
  • Market Diversification: Exhaustive information about new products, growing geographies, recent developments, and investments in the medication management market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the medication management market.
1 INTRODUCTION

1.1 OBJECTIVES OF THE STUDY
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 RESEARCH METHODOLOGY
  1.5.1 MARKET SIZE ESTIMATION
  1.5.2 MARKET CRACKDOWN AND DATA TRIANGULATION
  1.5.3 KEY DATA FROM SECONDARY SOURCES
  1.5.4 KEY DATA FROM PRIMARY SOURCES
  1.5.5 ASSUMPTIONS FOR THE STUDY

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS

3.1 GROWING DEMAND IN EMERGING MARKETS AIDING GROWTH OF THE GLOBAL MEDICATION MANAGEMENT SYSTEMS MARKET
3.2 GREATER UPTAKE OF CPOE AND MEDICATION ADMINISTRATION SYSTEMS TO OFFER SIGNIFICANT GROWTH OPPORTUNITIES
3.3 TECHNOLOGICAL ADVANCEMENTS DRIVING THE MARKET GROWTH
3.4 HEALTHCARE REFORMS TO AID PROMISING GROWTH IN THE MEDICATION MANAGEMENT SERVICES MARKET

4 MARKET OVERVIEW

4.1 INTRODUCTION
4.2 MARKET SEGMENTATION
4.3 MARKET DYNAMICS
  4.3.1 MARKET DRIVERS
    4.3.1.1 Technological Innovations Propelling the Market Growth
    4.3.1.2 Provision for Medication Management Services under Healthcare Reforms Fueling Growth
    4.3.1.3 Growth in Aging Population and High Incidences of Chronic Illness Accelerating Demand for Medication Management Systems
    4.3.1.4 Healthcare Cost-reduction Measures to Support Growth of the Medication Management Systems Market
  4.3.2 MARKET RESTRAINTS
    4.3.2.1 Reluctance Among Healthcare Providers to Adopt Medication Management Systems Hinders Market Growth
    4.3.2.2 High Implementation and Maintenance Expenses Restrain Market Growth
  4.3.3 MARKET OPPORTUNITIES
    4.3.3.1 Emerging Countries Offer Huge Potential For The Medication Management Market
    4.3.3.2 Increasing Focus on Value-based Medicine Promoting Market Growth
  4.3.4 MARKET TRENDS
    4.3.4.1 Various Agreements and Acquisitions by Leading Vendors to Enhance Their Production Capabilities and Market Presence
4.4 GLOBAL MARKET SHARE ANALYSIS

5 GLOBAL MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE

5.1 INTRODUCTION
  5.1.1 COMPUTERIZED PHYSICIAN ORDER ENTRY
  5.1.2 CLINICAL DECISION SUPPORT SYSTEMS
  5.1.3 ADMINISTRATION SOFTWARE
    5.1.3.1 Electronic Medication Administration Record (eMAR)
    5.1.3.2 Barcode Medication Administration (BCMA)
  5.1.4 INVENTORY MANAGEMENT SYSTEMS
  5.1.5 AUTOMATED DISPENSING SYSTEMS
    5.1.5.1 Centralized Automated Dispensing Systems
      5.1.5.1.1 Robots/Robotic Automated Dispensing Systems
      5.1.5.1.2 Carousels
    5.1.5.2 Decentralized Automated Dispensing Systems
      5.1.5.2.1 Pharmacy-based Automated Dispensing Systems
      5.1.5.2.2 Ward-based Automated Dispensing Systems
      5.1.5.2.3 Automated Unit Dose Dispensing Systems
  5.1.6 MEDICATION ASSURANCE SYSTEMS

6 GLOBAL MEDICATION MANAGEMENT SERVICES MARKET, BY TYPE

6.1 INTRODUCTION
6.2 POINT-OF-CARE VERIFICATION
6.3 MEDICATION ANALYTICS
6.4 ADVERSE DRUG EFFECTS SURVEILLANCE

7 GLOBAL MEDICATION MANAGEMENT MARKET, BY MODE OF DELIVERY

7.1 INTRODUCTION
7.2 ON-PREMISE MODEL
7.3 WEB-BASED MODEL
7.4 CLOUD-BASED MODEL

8 GLOBAL MEDICATION MANAGEMENT MARKET, BY END USER

8.1 INTRODUCTION
8.2 HOSPITALS
8.3 PHARMACIES
8.4 OTHERS HEALTHCARE INSTITUTIONS

9 GLOBAL MEDICATION MANAGEMENT MARKET, BY GEOGRAPHY

9.1 INTRODUCTION
9.2 NORTH AMERICA
  9.2.1 U.S.
  9.2.2 CANADA
9.3 EUROPE
  9.3.1 GERMANY
  9.3.2 U.K.
  9.3.3 FRANCE
  9.3.4 ITALY
  9.3.5 SPAIN
  9.3.6 REST OF EUROPE (ROE)
9.4 ASIA-PACIFIC
  9.4.1 JAPAN
  9.4.2 CHINA
  9.4.3 INDIA
  9.4.4 REST OF ASIA-PACIFIC (ROAPAC)
9.5 REST OF THE WORLD (ROW)
  9.5.1 MIDDLE EAST AND AFRICA
  9.5.2 LATIN AMERICA

10 COMPETITIVE LANDSCAPE

10.1 INTRODUCTION
10.2 NEW PRODUCT LAUNCHES
10.3 MERGERS AND ACQUISITIONS
10.4 PARTNERSHIPS, COLLABORATIONS, AGREEMENTS, AND ALLIANCES
10.5 EXPANSIONS
10.6 OTHER DEVELOPMENTS

11 COMPANY PROFILES (OVERVIEW, FINANCIALS, PRODUCTS & SERVICES, STRATEGY, & DEVELOPMENTS)

11.1 ALLSCRIPTS HEALTHCARE SOLUTIONS, INC.
11.2 CAREFUSION CORPORATION
11.3 CERNER CORPORATION
11.4 GE HEALTHCARE
11.5 MCKESSON CORPORATION
11.6 MEDITECH
11.7 OMNICELL, INC.
11.8 OPTUM INC.
11.9 QUADRAMED CORPORATION
11.10 SIEMENS HEALTHCARE (Details on Financials, Product & Services, Strategy, & Developments might not be captured in case of unlisted companies.)

APPENDIX

LIST OF TABLES

TABLE 1 GLOBAL MEDICATION MANAGEMENT SOFTWARE MARKET, BY TYPE, 2012–2019 ($MILLION)
TABLE 2 GLOBAL COMPUTERIZED PHYSICIAN ORDER ENTRY (CPOE) SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 3 GLOBAL CLINICAL DECISION SUPPORT SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 4 GLOBAL ADMINISTRATION SOFTWARE MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 5 GLOBAL ADMINISTRATION SOFTWARE MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 6 GLOBAL ELECTRONIC MEDICATION ADMINISTRATION RECORDS SOFTWARE MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 7 GLOBAL BAR CODE MEDICATION ADMINISTRATION SOFTWARE MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 8 GLOBAL INVENTORY MANAGEMENT SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 9 GLOBAL AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY TYPE OF SOFTWARE, 2012–2019 ($MILLION)
TABLE 10 GLOBAL CENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY TYPE OF SOFTWARE, 2012–2019 ($MILLION)
TABLE 11 GLOBAL CENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 12 GLOBAL ROBOTIC AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 13 GLOBAL CAROUSELS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 14 GLOBAL DECENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY TYPE OF SOFTWARE, 2012–2019 ($MILLION)
TABLE 15 GLOBAL DECENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 16 GLOBAL PHARMACY-BASED DECENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 17 GLOBAL WARD-BASED DECENTRALIZED AUTOMATED DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 18 GLOBAL AUTOMATED UNIT-DOSE DISPENSING SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 19 GLOBAL MEDICATION ASSURANCE SYSTEMS MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 20 GLOBAL MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE OF SERVICE, 2012–2019 ($MILLION)
TABLE 21 GLOBAL MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 22 GLOBAL POINT-OF-CARE VERIFICATION SERVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 23 GLOBAL MEDICATION ANALYTICS SERVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 24 GLOBAL ADE SURVEILLANCE SERVICES MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 25 GLOBAL MEDICATION MANAGEMENT MARKET, BY DELIVERY MODE, 2012–2019 ($MILLION)
TABLE 26 GLOBAL ON-PREMISE MEDICATION MANAGEMENT MARKET, BY GEOGRAPHY, 2012-2019 ($MILLION)
TABLE 27 GLOBAL WEB-BASED MEDICATION MANAGEMENT MARKET, BY GEOGRAPHY, 2012-2019 ($MILLION)
TABLE 28 GLOBAL CLOUD-BASED MEDICATION MANAGEMENT MARKET, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 29 GLOBAL MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 30 GLOBAL MEDICATION MANAGEMENT MARKET SIZE FOR HOSPITALS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 31 GLOBAL MEDICATION MANAGEMENT MARKET SIZE FOR PHARMACIES, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 32 GLOBAL MEDICATION MANAGEMENT MARKET SIZE FOR OTHER HEALTHCARE INSTITUTIONS, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 33 GLOBAL MEDICATION MANAGEMENT MARKET SIZE, BY GEOGRAPHY, 2012–2019 ($MILLION)
TABLE 34 NORTH AMERICA: MEDICATION MANAGEMENT MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 35 NORTH AMERICA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 36 NORTH AMERICA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 37 NORTH AMERICA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 38 NORTH AMERICA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 39 U.S.: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 40 U.S.: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 41 U.S.: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 42 U.S.: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 43 CANADA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 44 CANADA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 45 CANADA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 46 CANADA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 47 EUROPE: MEDICATION MANAGEMENT MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 48 EUROPE: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 49 EUROPE: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 50 EUROPE: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 51 EUROPE: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 52 GERMANY: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 53 GERMANY: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 54 GERMANY: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 55 GERMANY: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 56 U.K.: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 57 U.K.: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 58 U.K.: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 59 U.K.: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 60 FRANCE: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 61 FRANCE: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 62 FRANCE: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 63 FRANCE: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 64 ITALY: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 65 ITALY: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY, 2012–2019 ($MILLION)
TABLE 66 ITALY: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 67 ITALY: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 68 SPAIN: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 69 SPAIN: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 70 SPAIN: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 71 SPAIN: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 72 REST OF EUROPE: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 73 REST OF EUROPE: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 74 REST OF EUROPE: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 75 REST OF EUROPE: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 76 APAC: MEDICATION MANAGEMENT MARKET SIZE, BY COUNTRY, 2012–2019 ($MILLION)
TABLE 77 APAC: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 78 APAC: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 79 APAC: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 80 APAC: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 81 JAPAN: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 82 JAPAN: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 83 JAPAN: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 84 JAPAN: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 85 CHINA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 86 CHINA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 87 CHINA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 88 CHINA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 89 INDIA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 90 INDIA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 91 INDIA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 92 INDIA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 93 ROAPAC: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 94 ROAPAC: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 95 ROAPAC: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 96 ROAPAC: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 97 ROW: MEDICATION MANAGEMENT MARKET SIZE, BY REGION, 2012–2019 ($MILLION)
TABLE 98 ROW: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 99 ROW: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 100 ROW: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 101 ROW: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 102 MIDDLE EAST & AFRICA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 103 MIDDLE EAST & AFRICA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 104 MIDDLE EAST & AFRICA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 105 MIDDLE EAST & AFRICA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 106 LATIN AMERICA: MEDICATION MANAGEMENT SYSTEMS MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 107 LATIN AMERICA: MEDICATION MANAGEMENT SERVICES MARKET SIZE, BY TYPE, 2012–2019 ($MILLION)
TABLE 108 LATIN AMERICA: MEDICATION MANAGEMENT MARKET SIZE, BY MODE OF DELIVERY, 2012–2019 ($MILLION)
TABLE 109 LATIN AMERICA: MEDICATION MANAGEMENT MARKET SIZE, BY END USER, 2012–2019 ($MILLION)
TABLE 110 GROWTH STRATEGY MATRIX, 2011-2014
TABLE 111 NEW PRODUCT LAUNCHES, 2011–2014
TABLE 112 MERGERS AND ACQUISITIONS, 2011–2014
TABLE 113 PARTNERSHIPS, COLLABORATIONS, AGREEMENTS, AND ALLIANCES, 2011–2014
TABLE 114 EXPANSIONS, 2011-2014
TABLE 115 OTHER DEVELOPMENTS, 2011-2014

Computerized physician order entry (CPOE) is a system used by clinicians to enter their medication orders directly into a computer system. With CPOE, medication orders can directly be shared with pharmacy for dispensing prescriptions to respective patients.

During initial days of its launch, CPOE faced various challenges for its adoption by physicians and hospitals. A majority of the resistance was due to high cost of software implementation and general perception among healthcare providers that the use of CPOE systems increased their workload as compared to paper-based ordering method. Lack of user-friendliness and lower level of computer literacy among healthcare providers were major cont ributors to greater reluctance from healthcare providers to shift from paper-based medication ordering to CPOE. However, eventually the greater benefits of successful utilization of CPOE in the form of standardization of care, reduction in adverse drug events, and improved efficiency of care led to its growing adoption among healthcare providers in the developed countries across North America and Europe.

CPOE is currently one of the most preferred HCIT solutions used by healthcare providers across the world. The overall CPOE market is driven by its increasing adoption by physicians to ensure compliance with different guidelines from healthcare regulatory bodies, reduce healthcare cost, and shorten the length of hospital stay for patients. According to National Centre for Health Statistics (NCHS), in the U.S., the number of physicians using electronic means for sending prescriptions to pharmacies has increased from XX% to XX%, from 2010 to 2013.

Computerized physician order entry accounted for a XX% share of the global medication management market in 2013. This market is poised to reach $XX million by 2019 from $XX million in 2014, at a CAGR of XX% during the forecast period. By product type, CPOE will continue to remain the leading category, accounting for approximately XX% of the global medication management systems market in 2014. This market shows considerable growth opportunities during the forecast period as well. The CDSS and administration software segments are also large markets with shares of XX% and XX%, respectively, in 2014.

Geographically, the market is dominated by North America and Europe, which accounted for shares of XX% and XX%, respectively, of the global medication management systems market in 2013. This was followed by Asia-Pacific and the Rest of the World regions, which accounted for shares of XX% and XX%, respectively, to the total medication management systems market in 2013. China has emerged as the high-growth markets for the global medication management systems market, attributing to an increase in the aging population, rising incidences of chronic illnesses, and increased funding for modernization of healthcare in the past few years. Other than these, Latin America, Middle East, and Africa are also estimated to experience significant growth in this market in the next few years, owing to the increasing aging population and increasing number of American players investing in the market in these regions.

The global medication management market is a fragmented market with CareFusion Corporation (U.S.) and McKesson Corporation (U.S.) accounting for around XX% of the global market share in 2013. CareFusion commanded the largest share of XX% of the global medication management market in 2013, which was followed by McKesson with a share of XX%. Companies such as Allcripts, Omnicell, GE Healthcare, Siemens Healthcare, and Cerner Corporation also provide tough competition to the top two players. These companies collectively account for XX% of the global medication management market, with each of these companies accounting for not more than a XX% share.

The segment others occupies XX% of the market share, and this segment includes companies such as MediTech Inc. (U.S.), Omnicell, Inc. (U.S.), and QudraMed Inc. (U.S.).

Major players in this market include CareFusion Corporation (U.S.), McKesson Corporation (U.S.), Allscripts Healthcare Solutions Inc. (U.S.), Cerner Corporation (U.S.), and Siemens Healthcare (Germany).



More Publications